Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D as adjunctive treatment for ADHD in children
ChiCTR2200055133Phase 4Recruiting
- Sponsor
- Weifang Maternal and Child Health Care Hospital
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Therapy group (vitamin D) with Control group (placebo) (2 arms). Primary endpoint: Conners Parent Rating Scale score. Started Feb 2022; status: recruiting.
02
Drugs
vitamin d
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ChiCTR2200055133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055133.